CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-α and interferon-γ and tumor necrosis factor receptor-I-II upregulation

Haematologica

Volumn 88, Issue 2, 2003, Pages 148-158

  De Totero, Daniela ^a   Tazzari, Pier Luigi ^b   Capaia, Matteo ^d   Montera, Maria Pina ^d   Clavio, Marino ^d   Balleari, Enrico ^d   Foa, Robin ^c   Gobbi, Marco ^d  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Center for Advances Biotechnology ^*

Author keywords

Apoptosis; B CLL; CD40 triggering; Fludarabine

Indexed keywords

CASPASE 6; CD40 ANTIGEN; CHLORAMBUCIL; FLUDARABINE; GAMMA INTERFERON; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOCORTIN 5; MONOCLONAL ANTIBODY; PROPIDIUM IODIDE; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; CD40 LIGAND; DRUG DERIVATIVE; TUMOR NECROSIS FACTOR RECEPTOR; VIDARABINE;

ADULT; AGED; ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; CANCER CELL CULTURE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DOWN REGULATION; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; UPREGULATION; B CELL LEUKEMIA; BIOSYNTHESIS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SECRETION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD40; APOPTOSIS; AUTOCRINE COMMUNICATION; B-LYMPHOCYTES; CD40 LIGAND; FEMALE; HUMANS; INTERFERON TYPE II; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VIDARABINE;

EID: 0037608698     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Catovsky D, Foa R. The Lymphoid Leukaemias. Butterworths; London. 1990
2. Reed JC. Molecular biology of chronic lymphocytic leukemia: implications of therapy. Semin Hematol 1998;35:3-13.
3. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC. Bcl-2 hypomethylation and high level expression in B-cell chronic lymphocytic leukemia. Blood 1993;82:1820-8.
4. Robertson LE, Plunkett W, McConnel K, Keating MJ, McDonnel TJ. Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia 1996;10:456-9.
5. Dancescu M, Rubio-Trujillo M, Biron G, Delespesse G, Sarfati M. Interleukin-4 protects chronic lymphocytic leukemia B cells from death by apoptosis and upregulates bcl-2 expression. J Exp Med 1992;176:1319-26.
6. Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK. Interferon-γ inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 1993;177:213-8.
7. + T-cell subset in B-cell chronic lymphocytic leukaemia. Br J Haematol 1999;104:589-99.
8. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-43.
9. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 1992;267:10709-15.
10. Armitage R. Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol 1994;6:407-13.
11. Kamihira S, Yamada Y, Hirakata Y, Tsuruda K, Sugahara K, Tomonaga M, et al. Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias. Br J Haematol 1997;99:858-65.
12. Noelle RJ, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today 1992;13:431-3.
13. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881-922.
14. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994;367:425-8.
15. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993;72:291-300.
16. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993;259:990-3.
17. Di Santo JP, Bonnefoy JY, Gauchat JF, Fisher A, de Saint Basil G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 1993;361:541-3.
18. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993;361:539-41.
19. Cantwell M, Hua T, Pappas J, Kipps TJ. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nat Med 1997;3:984-9.
20. Dazzi F, D'Andrea E, Biasi G, De Silvestro G, Gaidano G, Schena M, et al. Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens. Clin Immunol Immunopathol 1995;75:26-32.
21. Kitada S, Zapata JM, Andreeff M, Reed JC. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia. BrJ Haematol 1999;106:995-1004.
22. Kato K, Cantwell MJ, Sharma S, Kipps TJ. Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. J Clin Invest 1998;101:1133-41.
23. Wang D, Freeman GJ, Levine H, Ritz J, Robertson MJ. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies. Br J Haematol 1997;97:409-17.
24. Van den Hove LE, Van Gool SW, Vandenberghe P, Bakkus M, Thielemans K, Boogaerts MA, et al. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules. Leukemia 1997;11:572-80.
25. Buhmann R, Nolte A, Westhaus D, Bertold E, Hallek M. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells. Blood 1999;93:1992-2002.
26. Wierda WG, Cantwell MJ, Woods SJ, Rassenti LZ, Prussak CE, Kipps TJ. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia. Blood 2000;96:2917-24.
27. Funakoshi S, Longo DL, Beckwith M, Conley DK, Tsarfaty G, Tsarfaty I, et al. Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood 1994;83:2787-94.
28. Bishop JY, Schattner EJ, Friedman SM. CD40 ligation impedes lymphoblastoid B cell proliferation and S-phase entry. Leuk Res 1998;22:319-27.
29. Tsubata T, Wu J, Honio T. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 1993;364:645-8.
30. Kehry MR. CD40-mediated signaling in B cells balancing cell survival, growth and death. J Immunol 1996;156:2345-8.
31. Ghia P, Boussiotis VA, Schultze JL, Cardoso AA, Dorfman DM, Gribben JG, et al. Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. Blood 1998;91:244-51.
32. Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Spriggs MK, et al. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur J Immunol 1993;23:2368-71.
33. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Ciinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-34.
34. de Totero D, Tazzari PL, DiSanto JP, di Celle PF, Raspadori D, Conte R, et al. Heterogeneous immunophenotype of granular lymphocyte expansions: differential expression of the CD8 α and CD8 β chains. Blood 1992;80:1765-73.
35. +) T cells. Blood 2001;97:2758-63.
36. Berrebi A, Bassou L, Shvidel L, Vorst E. Evaluation of in vitro apoptosis of B CLL cells: variations according to maturation stages and influence of dexamethasone, fludarabine and verapamil. Blood 1998;92:162b[abstract].
37. Grdisa M, Tang RP, Delmer A, Levy V, Gribben JG, Ajchembaum-Cymbalista F. Ligation of CD40 on B-cell chronic lymphocytic leukemia (B-CLL) cells promotes increased survival but does not impair fludarabine induced apoptosis. Blood 2000;96:159a[abstract].
38. Romano MF, Lamberti A, Tassone P, Alfinito F, Costantini S, Chiurazzi F, et al. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood 1998;92:990-5.
39. Faleiro L, Kobayashi R, Fearnhead H, Lazebnik Y. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. Embo J 1997;16:2271-81.
40. Trentin L, Zambello R, Agostini C, Siviero F, Adami F, Marcolongo R, et al. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood 1993;81:752-8.
41. Bojarska-Junak A, Rolinski J, Wasick-Szczepaneko E, Kaluzny Z, Dmoszynska A. Intracellular tumor necrosis factor production by T-and B-cells in B-cell chronic lymphocytic leukemia. Haematologica 2002;87:490-9.
42. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kB activation. Cell 1995;81:495-504.
43. Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, Huang DC, et al. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. Embo J 1999;18:3034-43.
44. Yang YC, Hsu TY, Chen JY, Yang CS, Lin RH. Tumour necrosis factor-α-induced apoptosis in cord blood T lymphocytes: involvement of both tumour necrosis factor receptor types 1 and 2. Br J Haematol 2001;115:435-41.
45. Messmer UK, Pered-Fernandez C, Mandersheid M, Pfeilschifter J. Dexamethasone inhibits TNF-α-induced apoptosis and IAP protein downregulation in MCF-7 cells. Br J Pharmacology 2001;133:467-76.
46. Suk K, Chang I, Kim YH, Kim S, Kim JY, Kim H, et al. Interferon γ (IFN γ) and tumor necrosis factor α synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNγ inhibits cytoprotective NF-κ B through STAT1/IRF-1 pathways. J Biol Chem 2001;276:13153-9.
47. Baker PK, Pettitt AR, Slupsky JR, Chen HJ, Glenn MA, Zuzel M, et al. Response of hairy cells to IFN-α involves induction of apoptosis through autocrine TNF-α and protection by adhesion. Blood 2002;100:647-53.